IntroductionImmunotherapy is an effective treatment for a subset of cancer patients. and expanding the benefits of immunotherapy to all cancer patients will require predictive biomarkers of response and immune-related adverse events (irAEs). To support correlative studies in immunotherapy clinical trials. we are developing highly validated assays for quantifying immunomodulatory prote... https://www.ealisboa.com/